Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2022-08-29 00:00:00 ET · period of report 2022-08-26 · accession 0001062993-22-018842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-29 | 2022-08-26 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $107.32 | +39.2K | 355.4K | +12% | +$4.21M |
| D | 2022-08-29 | 2022-08-26 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | F - Tax | $495.28 | -23.7K | 331.6K | -7% | -$11.76M |
| D | 2022-08-29 | 2022-08-26 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $0.00 | -39.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad B Common Stock | 2022-08-26 | M | A | 39,250 | $107.32 | 355,396 | D | — | — | |
| 2 | Common | Bio-Rad B Common Stock | 2022-08-26 | F | D | 23,749 | $495.28 | 331,647 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-08-26 | M | D | 39,250 | $0.00 | 0 | D | $107.32 · — to 2022-09-12 | 39,250 Bio-Rad B Common Stock | (F3) The option, representing a right to purchase a total of 39,250 shares, became exercisable in five equal annual installments beginning on September 12, 2013, which was the first anniversary of the date on which the option was granted. |